Related Experiment Video
Updated: Feb 16, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Recurrent Bioprosthetic Valve Thrombosis - Should Long-Term Anticoagulation Be Considered?
Matthew S Yong1, Robert Grant2, Pankaj Saxena1
1Department of Cardiothoracic Surgery, The Townsville Hospital, Townsville, Qld, Australia; James Cook University, Townsville, Qld, Australia.
Abstract:
Bioprosthetic valve thrombosis (BPVT) is an important and potentially reversible cause of valvular dysfunction. This complication can occur many years after surgery and understanding of the precise mechanisms and risk factors is limited. Anticoagulation therapy has been demonstrated to be effective in improving BPVT. However, the optimal duration of therapy and the risk of recurrence are unknown. Herein, we describe two cases-one of late BPVT and one of recurrence of BPVT after cessation of anticoagulation therapy.
More Related Videos
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
04:40Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Long-term Depression
Mitral Valve Prolapse I: Introduction